Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes

This paper presents using the fractional PImDn controller module which manipulates insulin infusion rate to maintain normoglycemia in subjects with type 1 diabetes. To prevent severe hypoglycemia, a conventional proportional controller is used to regulate glucagon infusion rate when the blood glucos...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Rafie Lak, O. Vahidi
Format: Article
Language:English
Published: Iranian Association of Chemical Engineering (IAChE) 2018-09-01
Series:Iranian Journal of Chemical Engineering
Subjects:
Online Access:https://www.ijche.com/article_76701_3b2298234120fdee4bdd42bad1b52f06.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850154881335164928
author A. Rafie Lak
O. Vahidi
author_facet A. Rafie Lak
O. Vahidi
author_sort A. Rafie Lak
collection DOAJ
description This paper presents using the fractional PImDn controller module which manipulates insulin infusion rate to maintain normoglycemia in subjects with type 1 diabetes. To prevent severe hypoglycemia, a conventional proportional controller is used to regulate glucagon infusion rate when the blood glucose levels fall below a threshold. Two sets of controller parameters are obtained and evaluated. For the first tuning set, clinical data from an oral glucose tolerance test taken from a group of healthy subjects are used to obtain the controller parameters such that it can mimic a real healthy pancreas. To obtain the second tuning set, the controller parameters are optimized through a sequential quadratic programming algorithm. Using the second tuning set, the in silico 2-hour postprandial test result and comparing it with the glucose concentration trajectory of the healthy subjects show that the controller performs well in returning the blood sugar levels into the glucose homeostasis while keeping the plasma insulin concentration within the acceptable physiological range. It is indicated that the manipulation of glucagon infusion rate is effective in hypoglycemia prevention if more aggressive controller settings are chosen or dysfunctional insulin infusion occurs.
format Article
id doaj-art-dc255532fb1c45b6a6a2a8d7c20a9716
institution OA Journals
issn 1735-5397
2008-2355
language English
publishDate 2018-09-01
publisher Iranian Association of Chemical Engineering (IAChE)
record_format Article
series Iranian Journal of Chemical Engineering
spelling doaj-art-dc255532fb1c45b6a6a2a8d7c20a97162025-08-20T02:25:08ZengIranian Association of Chemical Engineering (IAChE)Iranian Journal of Chemical Engineering1735-53972008-23552018-09-01153345276701Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetesA. Rafie Lak0O. Vahidi1School of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Narmak, P.O. Box: 16846, Tehran, IranSchool of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Narmak, P.O. Box: 16846, Tehran, IranThis paper presents using the fractional PImDn controller module which manipulates insulin infusion rate to maintain normoglycemia in subjects with type 1 diabetes. To prevent severe hypoglycemia, a conventional proportional controller is used to regulate glucagon infusion rate when the blood glucose levels fall below a threshold. Two sets of controller parameters are obtained and evaluated. For the first tuning set, clinical data from an oral glucose tolerance test taken from a group of healthy subjects are used to obtain the controller parameters such that it can mimic a real healthy pancreas. To obtain the second tuning set, the controller parameters are optimized through a sequential quadratic programming algorithm. Using the second tuning set, the in silico 2-hour postprandial test result and comparing it with the glucose concentration trajectory of the healthy subjects show that the controller performs well in returning the blood sugar levels into the glucose homeostasis while keeping the plasma insulin concentration within the acceptable physiological range. It is indicated that the manipulation of glucagon infusion rate is effective in hypoglycemia prevention if more aggressive controller settings are chosen or dysfunctional insulin infusion occurs.https://www.ijche.com/article_76701_3b2298234120fdee4bdd42bad1b52f06.pdftype 1 diabetescompartmental modelingglycemic controlfractional pimdn controllerinsulin and glucagon intravenous infusion
spellingShingle A. Rafie Lak
O. Vahidi
Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
Iranian Journal of Chemical Engineering
type 1 diabetes
compartmental modeling
glycemic control
fractional pimdn controller
insulin and glucagon intravenous infusion
title Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
title_full Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
title_fullStr Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
title_full_unstemmed Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
title_short Designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
title_sort designing a glycemic control strategy to maintain glucose homeostasis and prevent hypoglycemia for subjects with type 1 diabetes
topic type 1 diabetes
compartmental modeling
glycemic control
fractional pimdn controller
insulin and glucagon intravenous infusion
url https://www.ijche.com/article_76701_3b2298234120fdee4bdd42bad1b52f06.pdf
work_keys_str_mv AT arafielak designingaglycemiccontrolstrategytomaintainglucosehomeostasisandpreventhypoglycemiaforsubjectswithtype1diabetes
AT ovahidi designingaglycemiccontrolstrategytomaintainglucosehomeostasisandpreventhypoglycemiaforsubjectswithtype1diabetes